All dilution concerns aside, the conversion of all of the preferred stock and convertible debt into common shares is generally seen as a high level of confidence by those entities that there is a reasonably optimistic outlook for growth. The $12 Million the company raised should be sufficient until they start seeing revenues significant enough to pay for their operations moving forward. I know there are people who have differing opinions on here, but as for me, I'm sticking with the obvious signs.....and the ones that have over 43 million shares invested in the company.
I know most of you are aware of this, but for those potential investors: the company announced on their last conference call that the PST study has been accepted for publication in a major health journal, so that announcement should be coming out soon (increase in stock price). Also, the company has attracted a major investor already in New Enterprise Associates under their Growth Equity Opportunities Fund III, LLC (22,719,382 shares). NEA is a global investment firm that is focused on venture capital and growth equity investments, and is among the largest venture firms with approximately $11 billion in committed capital. Always a good thing when major players with real money to move the stock get involved....in my opinion, of course ;-)
Impressive. The company must believe they have a "plan" that will require some serious investment. The last go around, they only took $3 mil from Delta Dental. The only reason that the stock didn't really move today is that virtually no one even knows the company exists. Anyone know what we have to do, to be relisted on anything but the pinks?